Publication – Schizophrenia & Mania
Kozikowski, A. P.; Gaisina, I. N.; Yuan, H.; Petukhov, P. A.; Blond, S. Y.; Fedolak, A.; Caldarone, B.; McGonigle, P. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders. J Am Chem Soc 2007, 129, 8328-32.
Roy, K.; Murtie, J. C.; El-Khodor, B. F.; Edgar, N.; Sardi, S. P.; Hooks, B. M.; Benoit-Marand, M.; Chen, C.; Moore, H.; O'Donnell, P.; Brunner, D.; Corfas, G. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci U S A 2007, 104, 8131-6.
Stefansson, H.; Sigurdsson, E.; Steinthorsdottir, V.; Bjornsdottir, S.; Sigmundsson, T.; Ghosh, S.; Brynjolfsson, J.; Gunnarsdottir, S.; Ivarsson, O.; Chou, T. T.; Hjaltason, O.; Birgisdottir, B.; Jonsson, H.; Gudnadottir, V. G.; Gudmundsdottir, E.; Bjornsson, A.; Ingvarsson, B.; Ingason, A.; Sigfusson, S.; Hardardottir, H.; Harvey, R. P.; Lai, D.; Zhou, M.; Brunner, D.; Mutel, V.; Gonzalo, A.; Lemke, G.; Sainz, J.; Johannesson, G.; Andresson, T.; Gudbjartsson, D.; Manolescu, A.; Frigge, M. L.; Gurney, M. E.; Kong, A.; Gulcher, J. R.; Petursson, H.; Stefansson, K. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002, 71, 877-92.
Olivier, B.; Leahy, C.; Mullen, T.; Paylor, R.; Groppi, V. E.; Sarnyai, Z.; Brunner, D. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics? Psychopharmacology (Berl) 2001, 156, 284-90.
Grailhe, R.; Waeber, C.; Dulawa, S. C.; Hornung, J. P.; Zhuang, X.; Brunner, D.; Geyer, M. A.; Hen, R. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron 1999, 22, 581-91.
